Searchable abstracts of presentations at key conferences in endocrinology

ea0003s11 | Recent Advances in Biological Rhythms | BES2002

Photoperiodic regulation of the neuroendocrine system

Morgan P , Ross A , Mercer J , Barrett P

For many animals anticipation of future changes in environmental conditions is a critical adaptation for survival. Seasonal changes in reproductive activity, body weight and adiposity, metabolism and coat condition are examples of such adaptive physiology. Clearly each of these involves neuroendocrine control. The environmental cue that triggers these changes is photoperiod, which is translated into the hormonal signal, melatonin, a product of the pineal gland. A considerable ...

ea0003p173 | Growth and Development | BES2002

Developmental regulation of the mt1 melatonin receptor gene in the rat pituitary gland

Johnston J , Messager S , Barrett P , Hazlerigg D

Expression of the mt1 melatonin receptor has been described in both the pars tuberalis (PT) and pars distalis (PD) of the rat pituitary gland. Expression of mt1 mRNA and iodomelatonin (IMEL) binding sites is high in the neonate PD but rapidly declines over the initial weeks of postnatal life. In contrast, both mt1 mRNA and IMEL binding sites are preserved in the PT through to adulthood, leading to a marked tissue-specific expression profile.To identify ...

ea0085p61 | Diabetes 3 | BSPED2022

GAME-SET-MATCH mnemonic: an infographic to teach effective dynamic glucose management strategies improving time in range in children with type 1 diabetes using continuous glucose monitoring

Pemberton John S , Dias Renuka P , Barrett Timothy G , Kershaw Melanie , Krone Ruth , Uday Suma

Background: Continuous Glucose Monitoring (CGM) is now becoming the standard of care for children and young people with diabetes (CYPD). Due to a lack of validated education programmes, we created ‘The CGM Academy’ delivering evidence-based structured education. The results of the first 50 CYPD graduating from the academy demonstrated statistically significant improvement in time in range (TIR, 3.9-10.0 mmol/l) by 8.3% (P<0.001) and HbA1c by 3.8 mmol/mol...

ea0005p271 | Thyroid | BES2003

Serum TSH and thyroid autoantibodies in thyroidal and extrathyroidal disease

Smyth P , Kavanagh D , Smith D , Brennan C , Fleming F , Hill A , Mc|#Dermott E , O'Higgins N , Barrett P , Thompson C , Moriarty M

The relationship between serum TSH and thyroid autoantibodies is frequently used to classify thyroid disease both overt and subclinical. Further debate has centred on the validity of the cutoff point for serum TSH elevation (generally between 4-5 mU/l) which it has been suggested is inappropriately high. The significance of the presence of thyroid autoantibodies (hereafter termed antibody positivity) in extrathyroidal disease is unclear but an increased prevalence has been rep...